Homepage - Ophthalmology Advisor
Ophthalmology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and …
Prostaglandin Analogue Adherence Low, Attrition Rates High ...
Apr 22, 2025 · Patients with glaucoma often demonstrate poor adherence to prescribed treatment plans with prostaglandin analogues (PGAs), research published in the American Journal of …
Ocular Myasthenia Gravis Treatment Options Explained
Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized …
Vision Quality With Trifocal IOL Rated High Despite Occasional …
Aug 23, 2021 · Doctor performing eye surgery in modern clinic After 3 months, mean visual acuity with trifocal IOL was better than 20/25 at test distances, uncorrected and distance-corrected.
Expertscape Publishes Top 10 Specialists in Glaucoma
Oct 30, 2020 · Expertscape, a web platform that identifies and objectively ranks physicians and researchers that excel in the treatment and diagnosis of specific disease states, has released …
FDA Alerts: Ophthalmology Drug and Device Approvals
Drug Regulatory Updates. Susvimo: Diabetic Eye Conditions. The FDA has accepted the application for Susvimo ® (ranibizumab injection, Genentech) to treat diabetic macular edema …
Most Asymptomatic Retinal Detachments Do Not Require Surgery
Nov 1, 2022 · Observation without surgery may be a viable initial management strategy for most patients with asymptomatic retinal detachment (RD), according to a report published in …
Aflibercept 8 mg Improves Outcomes in nAMD - Ophthalmology …
Apr 10, 2025 · Aflibercept 8 mg therapy has a number of advantages for patients with neovascular age-related macular degeneration (nAMD) compared with aflibercept 2 mg, according to …
In-Office Meibomian Gland Dysfunction Management and …
Jun 25, 2024 · Meibomian gland dysfunction (MGD) affects approximately 35.8% of the world’s population, and is growing. Traditionally, the highest MGD rate has been seen among men 60 …
Photobiomodulation Treatment for Dry AMD Approved By FDA ...
Nov 15, 2024 · A photobiomodulation therapy device has received approval by the US Food and Drug Administration (FDA) to be marketed for the treatment of nonexudative (dry) age-related …